Liquid purification or separation – Processes – Separating
Patent
1994-08-02
1997-02-11
Kim, John
Liquid purification or separation
Processes
Separating
210194, 2104331, 210650, 210651, 210805, B01D 3700, B01D 6100
Patent
active
056017278
DESCRIPTION:
BRIEF SUMMARY
TECHNICAL FIELD
The present invention concerns a device and method for separating plasma from a biological fluid such as blood.
BACKGROUND OF THE INVENTION
An adult human contains about 5 liters of blood, of which red blood cells account for about 45% of the volume, white cells about 1%, and the balance being liquid blood plasma. Blood also contains large numbers of platelets. In view of the substantial therapeutic and monetary value of blood components such as red blood cells, platelets, and plasma, a variety of techniques have been developed to separate blood into its component fractions while ensuring maximum purity and recovery of each of the components.
Typically, donated blood is collected in a blood collection bag and separated by centrifugation into PRC and platelet-rich plasma (PRP) fractions, the latter of which is in current practice separated by a second centrifugation to provide plasma and PC. With respect to the second centrifugation step, the platelet concentrate is typically obtained from the PRP by "hard-spin" centrifugation (rotating at about 5000 G). This hard-spin compacts the platelets into a pellet or concentrate at the bottom of the test tube, flask, or bag. The plasma component is then removed or expressed to a separate bag or container, leaving the platelet component and some plasma behind. This platelet composition, which tends to form a dense aggregate, is subsequently dispersed to make PC. The dispersion step is usually carried out by gentle mixing, for example, by placing the bag on a moving table which rotates with a precessing tilted motion.
Platelet concentrate can also be prepared using apheresis of autologous blood. With this method, whole blood is removed from a single donor, and centrifuged into its component parts. The desired component is then harvested and the remainder of the blood is returned to the donor. This procedure allows collection of multiple units from one donor. Typically, a 2 to 3 hour apheresis procedure will produce a platelet product containing 3.times.10.sup.11 platelets, equivalent to about six to ten units of random donor platelets, i.e., a typical transfusion unit. The common practice with respect to platelet concentrate is to transfuse a pool of six to ten units of platelets per administration, containing a total of about 300 to 700 ml of platelet concentrate.
Blood bank personnel have responded to the increased need for blood components by attempting to increase packed red cell (PRC) and platelet concentrate (PC) yields in a variety of ways. For example, in separating the PRP from PRC, blood bank personnel have attempted to ensure that the entire PRP fraction is recovered, but this may be counter-productive, since the PRP, and the PC subsequently extracted from it, are frequently contaminated by red cells, giving a pink or red color to the normally light yellow PC. The presence of red cells in PC is so highly undesirable that pink or red PC is frequently discarded, or subjected to recentrifugation, both of which increase operating costs and are labor intensive.
Additionally, freshly donated blood contains platelets varying in age from newly-formed to 9 days or more in age. Newly-formed platelets are larger, and are generally believed to be more active. Because the younger platelets are larger, they tend to sediment faster during the first centrifugation step, and consequently are present in larger numbers in the PRP nearest to the red cell interface. Thus, although it is desirable to reclaim a larger proportion of the younger, more active platelets, attempting to obtain a greater quantity poses a risk of contamination with red cells.
Typical techniques for processing platelets or platelet concentrate may reduce the yield and/or adversely affect the platelets. For example, as noted earlier, during the separation of PRP from PRC, it is difficult to efficiently obtain the maximum yield of platelets while preventing red cells from entering the plasma. Additionally, hard spin centrifugation and dispersion is labor intensive and it is believed that
REFERENCES:
patent: 3610418 (1971-10-01), Calderwood
patent: 3623610 (1971-11-01), Olsen et al.
patent: 3705100 (1972-12-01), Blatt et al.
patent: 4075091 (1978-02-01), Bellhouse
patent: 4178248 (1979-12-01), Porter et al.
patent: 4212742 (1980-07-01), Solomon et al.
patent: 4381775 (1983-05-01), Nose et al.
patent: 4604208 (1986-08-01), Chu et al.
patent: 4619639 (1986-10-01), Nose et al.
patent: 4636309 (1987-01-01), Bellhouse
patent: 4636310 (1987-01-01), Bellhouse
patent: 4680025 (1987-07-01), Kruger et al.
patent: 4746436 (1988-05-01), Kopp et al.
patent: 4753733 (1988-06-01), Ramstack
patent: 4769150 (1988-09-01), Ramstack
patent: 4800022 (1989-01-01), Loenard
patent: 4806247 (1989-02-01), Schoendorfer et al.
patent: 4845132 (1989-07-01), Masuoka et al.
patent: 4880548 (1989-11-01), Pall et al.
patent: 4888115 (1989-12-01), Marinaccio et al.
patent: 4898573 (1990-02-01), Takenaka et al.
patent: 4925572 (1990-05-01), Pall
patent: 4933092 (1990-06-01), Aunet et al.
patent: 4980297 (1990-12-01), Haynes et al.
patent: 4995967 (1991-02-01), Van Driessche
patent: 5008012 (1991-04-01), Hagihara et al.
patent: 5013437 (1991-05-01), Trimmer et al.
patent: 5049268 (1991-09-01), Kopf
patent: 5069789 (1991-12-01), Mohn et al.
patent: 5100564 (1992-03-01), Pall et al.
patent: 5217627 (1993-06-01), Pall et al.
patent: 5266219 (1993-11-01), Pall et al.
Transfusion, vol. 21, No. 5, 1981, Wiltbank, et al., "Filtration Plasmapheresis In Vivo", pp. 502-510.
Artificial Organs, vol. 13, (1):43-51, 1989, Beaudoin, et al., "Plasma Filtration in Couette Flow Membrane Devices".
Ann Clin Biochem, 28:55-59, 1991, van Oudheusden, et al., "A Multilayer Membrane . . . Primary Health Care".
Bormann Thomas J.
Gsell Thomas C.
Matkovich Vlado I.
Pall David B.
Kim John
Pall Corporation
LandOfFree
Device and method for separating plasma from a biological fluid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Device and method for separating plasma from a biological fluid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Device and method for separating plasma from a biological fluid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-339179